Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tarsus Pharmaceuticals, Inc. (TARS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 44,290,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Co.'s primary product candidate, TP-03, is an investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Co. is developing product candidates to address targeted diseases with unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease, TP-04 for the potential treatment of rosacea, and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 10,506
Total Buy Value $0 $0 $0 $178,661
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 62,485 62,485 107,930 627,456
Total Sell Value $2,995,441 $2,995,441 $4,195,326 $10,212,071
Total People Sold 6 6 7 9
Total Sell Transactions 18 18 20 51
End Date 2025-01-19 2024-10-18 2024-04-19 2023-04-20

   
Records found: 244
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Azamian Bobak R. President/CEO and Board Chair   •       •      –    2025-03-20 4 S $50.11 $427,639 D/D (8,534) 53,635     -
   Wahl Bryan General Counsel   •       –      –    2025-03-20 4 S $50.11 $154,539 D/D (3,084) 51,712     -
   Mottiwala Aziz Chief Commercial Officer   •       –      –    2025-03-20 4 S $50.11 $168,620 D/D (3,365) 65,057     -
   Whitfield Dianne C. Chief Human Resources Officer   •       –      –    2025-03-20 4 S $50.11 $107,085 D/D (2,137) 46,355     -
   Neervannan Seshadri Chief Operating Officer   •       –      –    2025-03-20 4 S $50.11 $122,018 D/D (2,435) 79,682     -
   Farrow Jeffrey S See Remarks   •       –      –    2025-03-20 4 S $50.11 $59,430 D/D (1,186) 22,431     -
   Azamian Bobak R. President/CEO and Board Chair   •       •      –    2025-03-19 4 S $47.40 $405,317 D/D (8,551) 62,169     -
   Wahl Bryan General Counsel   •       –      –    2025-03-19 4 S $47.40 $154,571 D/D (3,261) 54,796     -
   Mottiwala Aziz Chief Commercial Officer   •       –      –    2025-03-19 4 S $47.40 $168,602 D/D (3,557) 68,422     -
   Whitfield Dianne C. Chief Human Resources Officer   •       –      –    2025-03-19 4 S $47.40 $107,077 D/D (2,259) 48,492     -
   Neervannan Seshadri Chief Operating Officer   •       –      –    2025-03-19 4 S $47.40 $120,538 D/D (2,543) 82,117     -
   Farrow Jeffrey S See Remarks   •       –      –    2025-03-19 4 S $47.40 $59,440 D/D (1,254) 23,617     -
   Azamian Bobak R. President/CEO and Board Chair   •       •      –    2025-03-18 4 S $46.29 $330,094 D/D (7,131) 70,720     -
   Wahl Bryan General Counsel   •       –      –    2025-03-18 4 S $46.29 $154,655 D/D (3,341) 58,057     -
   Mottiwala Aziz Chief Commercial Officer   •       –      –    2025-03-18 4 S $46.29 $168,634 D/D (3,643) 71,979     -
   Whitfield Dianne C. Chief Human Resources Officer   •       –      –    2025-03-18 4 S $46.29 $107,161 D/D (2,315) 50,751     -
   Neervannan Seshadri Chief Operating Officer   •       –      –    2025-03-18 4 S $46.29 $120,585 D/D (2,605) 84,660     -
   Farrow Jeffrey S See Remarks   •       –      –    2025-03-18 4 S $46.29 $59,436 D/D (1,284) 24,871     -
   Mottiwala Aziz Chief Commercial Officer   •       –      –    2025-03-15 4 OE $0.00 $0 D/D 20,957 75,622     -
   Whitfield Dianne C. Chief Human Resources Officer   •       –      –    2025-03-15 4 OE $0.00 $0 D/D 18,885 53,066     -
   Neervannan Seshadri Chief Operating Officer   •       –      –    2025-03-15 4 OE $0.00 $0 D/D 21,264 87,265     -
   Azamian Bobak R. President/CEO and Board Chair   •       •      –    2025-03-15 4 OE $0.00 $0 D/D 51,395 77,851     -
   Farrow Jeffrey S See Remarks   •       –      –    2025-03-15 4 OE $0.00 $0 D/D 8,019 26,155     -
   Wahl Bryan General Counsel   •       –      –    2025-03-15 4 OE $0.00 $0 D/D 19,213 61,398     -
   Goldberg Andrew D. Director   –       •      –    2025-03-07 4 OE $12.89 $90,230 D/D 7,000 13,350     -
  244 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us